The Role of EZH2 in the Induction and Maintenance of Acute Myeloid LeukaemiaFaisal BasheerApollo (University of Cambridge)February 27, 201810.17863/cam.20724Cited by 0SaveCiteExport RISWatch citationsRelated PapersReal-world outcomes of newly diagnosed AML treated with venetoclax and azacitidine or low-dose cytarabine in the UK NHS|Blood Neoplasia|2024|36RNAmut: robust identification of somatic mutations in acute myeloid leukemia using RNA-sequencing|Haematologica|2019|24Outcomes with single-agent gilteritinib for relapsed or refractory <i>FLT3</i>-mutant AML after contemporary induction therapy|Blood Advances|2024|10